Indexed in Journament
Advanced Medicine
ISSN 3105-6725,3105-6733· EN
Login or register to claim ownership or editorship of this journal.
34.8
050100
The Journament Score is computed from platform statistics — reader engagement,
accessibility, publication timeliness, keyword breadth, community impact and content
distribution — into a single 0–100 figure, recalculated as new articles and metadata
are indexed. Dimensions that cannot be measured for this journal are excluded rather
than estimated. It is independent of the paid AI Quality Analysis, which never
affects this score or the ranking.
Full methodology →
About This Journal
Advanced Medicine
ISSN 3105-6725 (Print)
ISSN 3105-6733 (Online)
CODEN: XYABBJ
(International Standard Serial Number · Globally Unique Identifier, assigned by the Chemical Abstracts Service (CAS), USA)
Publication Model: Gold Open Access (Gold OA), licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Full texts are permanently and freely accessible.
Publisher: Macao Chinese and Foreign Medical Publishing Co., Limited
Publication Frequency: Bimonthly
Publication Languages: Chinese, English
Submission Language: Chinese (Chinese title, abstract, keywords, author affiliations and names are required)
Distribution Support: China International Book Trading Corporation (CIBTC)
Import Registration Number: G015Z124
This journal has been indexed by all authoritative academic databases worldwide. It is committed to promoting the global dissemination of high-quality research, and collaborating with scholars across the globe to build an open, collaborative and forward-looking international academic community.
I. Core Position and Vision
Advanced Medicine is an international academic journal focusing on medical innovation and clinical translation. It devotes itself to building a cutting-edge and solid bridge among basic medical research, innovative drug development and clinical diagnosis and treatment practice, driving the translation of scientific discoveries into clinical applications. We highly focus on the latest breakthroughs in precision medicine, novel therapies (including cell therapy, gene therapy, etc.) and translational medicine fields. In particular, we encourage interdisciplinary research that integrates multidisciplinary wisdom, striving to provide a solid academic engine and knowledge foundation for the development of the global innovation system.
II. Major Call for Papers
Original and high-quality research papers, reviews and methodological discussions are long-term solicited in the following fields:
Precision medicine and personalized pharmacotherapy
Innovative drug design and development (small molecule drugs, macromolecular biopharmaceuticals, etc.)
Cell and gene therapy technologies
Biologics and novel vaccine research and development
Preclinical research and translational medicine
Innovative clinical diagnosis and treatment protocols (including clinical trial design, real-world research)
Pharmaceutical dosage forms and formulation technologies
Medical artificial intelligence and digital medicine
Novel therapies for rare and major diseases
Pharmacoeconomics and health policy research
III. Submission Requirements
Manuscript Nature
Submissions must be original, unpublished academic achievements with clear scientific innovation or clinical translation potential.
Language Requirement
The main text of manuscripts shall be written in Chinese.
Mandatory Information
Please provide the following information with Chinese and English correspondence in full when submitting:
Article title (Chinese & English)
Author information: Names and affiliated institutions of all authors (Chinese & English), as well as brief profiles of the first author/corresponding author (including research directions and email addresses)
Abstract: Structured abstracts in Chinese and English, clearly elaborating the research objectives, methods, core findings and main conclusions
Keywords: 3 to 5 keywords in both Chinese and English
Submission Channel
Please submit manuscripts through the journal's official online submission system: http://tg.scionline2025.com/01/
Peer Review
The journal implements a strict international double-blind peer review system to ensure the academic quality and rigor of published achievements.
IV. Journal Development and Objectives
The journal aspires to become an influential academic journal with both authority and practical value in the field of medical innovation in China and even the world. We aim to build an open, rigorous and dynamic academic community of medicine. By promoting the dissemination and exchange of high-level research results, we effectively connect laboratory research, development and industrial application, and contribute knowledge and wisdom to addressing major global health challenges and advancing the cause of human health.
| Short Name | Adv. Med. |
|---|---|
| Abbreviated Name | Adv Med |
| ISSN | 3105-6725,3105-6733 |
| URL | https://xyy.scionline2025.com |
| Author Instructions | https://xyy.scionline2025.com/Aboutus.asp?Aboutusorder=1 |
Quality Profile
4 of 12 dimensions measured
This journal
Average of scored journals
Platform statistics — the free Journament Score
AI Quality Analysis — separate paid product, ranks nothing
8 of the 12 dimensions could not be measured for this journal. They are left out entirely rather than plotted as zero, and with 4 dimensions measured there is not enough of a profile to draw as a shape.
Show the numbers
| Dimension | This journal | Corpus average |
|---|---|---|
| Engagement | 30.9 | 30.1 |
| Accessibility | 30.0 | 17.9 |
| Timeliness | — | 19.2 |
| Diversity | — | 28.8 |
| Innovation | 70.0 | 31.2 |
| Community Impact | 3.6 | 13.4 |
| Content Distribution | — | 88.4 |
| Content Quality | — | 55.5 |
| Ethics & Transparency | — | 40.2 |
| Editorial Standards | — | 33.4 |
| Publication Regularity | — | 53.2 |
| Geographic Reach | — | 30.8 |
Articles (0)
No articles found
This journal doesn't have any indexed articles yet.